These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 39213073)

  • 1. The Profile of the Italian Centers for Cognitive Disorders and Dementia in the Context of New Drugs in Alzheimer's Disease.
    Giaquinto F; Lorenzini P; Salvi E; Carnevale G; Vaccaro R; Matascioli F; Corbo M; Locuratolo N; Vanacore N; Bacigalupo I; ;
    J Alzheimers Dis; 2024; 101(2):509-524. PubMed ID: 39213073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new national survey of centers for cognitive disorders and dementias in Italy.
    Bacigalupo I; Giaquinto F; Salvi E; Carnevale G; Vaccaro R; Matascioli F; Remoli G; Vanacore N; Lorenzini P;
    Neurol Sci; 2024 Feb; 45(2):525-538. PubMed ID: 37592124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A National Survey of Centers for Cognitive Disorders and Dementias in Italy.
    Canevelli M; Di Pucchio A; Marzolini F; Mayer F; Massari M; Salvi E; Palazzesi I; Lacorte E; Bacigalupo I; Di Fiandra T; Vanacore N
    J Alzheimers Dis; 2021; 83(4):1849-1857. PubMed ID: 34459403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nationwide survey of Italian Centers for Cognitive Disorders and Dementia on the provision of care for international migrants.
    Canevelli M; Cova I; Remoli G; Bacigalupo I; Salvi E; Maestri G; Nicotra A; Valletta M; Ancidoni A; Sciancalepore F; Cascini S; Bargagli AM; Pomati S; Pantoni L; Vanacore N; ;
    Eur J Neurol; 2022 Jul; 29(7):1892-1902. PubMed ID: 35189011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of neuropsychological tests for the diagnosis of dementia: a survey of Italian memory clinics.
    Di Pucchio A; Vanacore N; Marzolini F; Lacorte E; Di Fiandra T; ; Gasparini M
    BMJ Open; 2018 Mar; 8(3):e017847. PubMed ID: 29599390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    Rossini PM; Cappa SF; Lattanzio F; Perani D; Spadin P; Tagliavini F; Vanacore N
    J Alzheimers Dis; 2019; 72(2):373-388. PubMed ID: 31594234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal and spatial patterns in the prescriptions of disease-modifying therapies for multiple sclerosis. Results from the Italian Multiple Sclerosis and Related Disorders Register.
    Lepore V; Paletta P; Bosetti C; Santucci C; Ponzio M; Pupillo E; Leone MA; Bergamaschi R; Mosconi P;
    Mult Scler Relat Disord; 2024 Jul; 87():105638. PubMed ID: 38713966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating the future of Alzheimer's care in Ireland - a service model for disease-modifying therapies in small and medium-sized healthcare systems.
    Leroi I; Dolphin H; Dinh R; Foley T; Kennelly S; Kinchin I; O'Caoimh R; O'Dowd S; O'Philbin L; O'Reilly S; Trepel D; Timmons S
    BMC Health Serv Res; 2024 Jun; 24(1):705. PubMed ID: 38840115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease.
    Assunção SS; Sperling RA; Ritchie C; Kerwin DR; Aisen PS; Lansdall C; Atri A; Cummings J
    Alzheimers Res Ther; 2022 Apr; 14(1):54. PubMed ID: 35440022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
    Jobst KA; Barnetson LP; Shepstone BJ
    Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.
    Chan CC; Fage BA; Burton JK; Smailagic N; Gill SS; Herrmann N; Nikolaou V; Quinn TJ; Noel-Storr AH; Seitz DP
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011414. PubMed ID: 31521064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous social behaviors discriminate behavioral dementias from psychiatric disorders and other dementias.
    Rankin KP; Santos-Modesitt W; Kramer JH; Pavlic D; Beckman V; Miller BL
    J Clin Psychiatry; 2008 Jan; 69(1):60-73. PubMed ID: 18312039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias.
    Corey-Bloom J
    Int Psychogeriatr; 2002; 14 Suppl 1():51-75. PubMed ID: 12636180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB 1.0): development and normative data.
    Conca F; Esposito V; Rundo F; Quaranta D; Muscio C; Manenti R; Caruso G; Lucca U; Galbussera AA; Di Tella S; Baglio F; L'Abbate F; Canu E; Catania V; Filippi M; Mattavelli G; Poletti B; Silani V; Lodi R; De Matteis M; Stanzani Maserati M; Arighi A; Rotondo E; Tanzilli A; Pace A; Garramone F; Cavaliere C; Pardini M; Rizzetto C; Sorbi S; Perri R; Tiraboschi P; Canessa N; Cotelli M; Ferri R; Weintraub S; Marra C; Tagliavini F; Catricalà E; Cappa SF
    Alzheimers Res Ther; 2022 Aug; 14(1):113. PubMed ID: 35982477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI).
    Limongi F; Noale M; Bianchetti A; Ferrara N; Padovani A; Scarpini E; Trabucchi M; Maggi S;
    Aging Clin Exp Res; 2019 Jan; 31(1):101-107. PubMed ID: 30178442
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.